Company type
A biopharmaceutical company developing synthetic hemoglobin products for use in blood transfusion.Funding rounds
Acquisition
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
| |
Baxter International Inc | 189,000,000 (USD 189,000,000) |
| Investor | Profile | Country | |
|---|---|---|---|
| |
Alpha Capital Partners | Family office making direct private equity investments, managing an internal hedge fund, and, on a limited basis, investing in US real estate. |
Investment activity status
Active investor